ACH · XBRL financial data

Accendra Health financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (ACH's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	8,480	9,785	9,955	10,334	10,701	2,762
Cost of revenue	7,199	8,272	8,129	8,209	8,482	1,473
Gross profit	1,281	1,513	1,826	2,125	2,219	—
Research and development	—	12	12	13	13	—
Selling, general and administrative	1,041	1,117	1,634	1,814	1,910	1,068
Other operating income (expense)	2	6	5	(7)	(13)	—
Operating income (loss)	204	368	143	105	(208)	27
Interest expense	83	48	129	158	144	107
Income tax expense (benefit)	22	55	(11)	(13)	5	1
Net income (loss)	30	222	22	(41)	(363)	(1,101)
Earnings per share, basic USD per share	0.47	3.05	0.30	(0.54)	(4.73)	(14.31)
Earnings per share, diluted USD per share	0.47	2.94	0.29	(0.54)	(4.73)	(14.31)
Weighted average shares, basic millions of shares	63	73	74	76	77	77
Weighted average shares, diluted millions of shares	64	75	76	76	77	77

Fiscal years (ACH's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	83	56	69	243	49	282
Inventory	1,234	1,496	1,334	1,111	1,132	74
Total current assets	2,136	2,322	2,295	2,103	2,021	548
Property and equipment, net	—	—	—	—	249	256
Right-of-use asset	145	194	281	297	356	109
Goodwill	394	390	1,637	1,639	1,331	1,228
Total assets	3,336	3,537	5,386	5,093	4,656	2,452
Accounts payable	1,000	1,002	1,147	1,172	1,252	364
Current portion of long-term debt	40	—	18	207	46	250
Total current liabilities	1,346	1,344	1,566	1,892	1,874	947
Long-term debt	986	—	—	—	—	—
Lease liability, non-current	120	162	215	222	286	70
Total liabilities	2,624	2,598	4,441	4,169	4,091	2,913
Retained earnings (accumulated deficit)	167	388	410	369	6	(1,080)
Total stockholders' equity	712	939	946	924	565	(461)
Total liabilities and equity	3,336	3,537	5,386	5,093	4,656	2,452
Common shares outstanding (cover page) millions of shares	73	76	76	77	77	76

Fiscal years (ACH's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	30	222	22	(41)	(363)	(1,101)
Stock-based compensation	20	25	21	23	27	13
Depreciation and amortization	93	91	229	287	265	215
Net cash from operating activities	339	124	325	741	161	—
Purchases of property and equipment	50	41	158	191	211	191
Net cash from investing activities	80	(54)	(1,804)	(137)	(117)	144
Proceeds from issuing common stock	190	0	0	—	—	—
Share repurchases	—	—	—	—	—	10
Dividends paid	1	1	0	0	—	—
Proceeds from long-term debt	155	—	—	—	—	—
Repayments of long-term debt	617	553	5	321	244	—
Net cash from financing activities	(379)	(129)	1,497	(417)	(268)	188
Net change in cash	50	(62)	14	187	(224)	233

SIC 5047 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 5047 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Accendra Health	7.7	613	not reported	76.9M	—	Q2 FY26 10-QJun 30, 2026
PC Connection	125	874	9.7*	25.2M	—	Q3 FY26 10-QSep 30, 2026
Scansource	88	953*	(2.3)*	20.1M	38.9 quarters	Q4 FY26 10-KJun 30, 2026
Ingram Micro Holding	1,004	15,220	251*	230.1M	—	Q3 FY26 10-QSep 26, 2026
Climb Global Solutions	67	220	12*	18.7M	—	Q3 FY26 10-QSep 30, 2026
Eplus	449	649	76	26.1M	—	Q1 FY27 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.